| Literature DB >> 23620845 |
Sobia Idrees1, Usman A Ashfaq.
Abstract
Dengue virus infection has become a global threat affecting around 100 countries in the world. Currently, there is no licensed antiviral agent available against dengue. Thus, there is a strong need to develop therapeutic strategies that can tackle this life threatening disease. RNA interference is an important and effective gene silencing process which degrades targeted RNA by a sequence specific process. Several studies have been conducted during the last decade to evaluate the efficiency of siRNA in inhibiting dengue virus replication. This review summarizes siRNAs as a therapeutic approach against dengue virus serotypes and concludes that siRNAs against virus and host genes can be next generation treatment of dengue virus infection.Entities:
Keywords: Dengue haemorrhagic fever; Dengue virus; RNA interference; Small interference RNA
Mesh:
Substances:
Year: 2013 PMID: 23620845 PMCID: PMC3631757 DOI: 10.1016/S2221-1691(13)60057-X
Source DB: PubMed Journal: Asian Pac J Trop Biomed ISSN: 2221-1691